At this point a New Yorkregistered pharmacy can lawfully compound BPC-157 on a prescription, and peptide therapy becomes a fully standard part of practice. What the science actually shows Legal availability and clinical evidence are two different questions, and its worth being clear-eyed about both. The preclinical work on BPC-157 is genuinely interesting
Sample meal plan Breakfast: Weetabix, Oatibix or Ready Brek with plenty of skimmed milk OR high protein yogurt pot or pouch Lunch and Dinner ideas: Puree chicken with potato and vegetables Puree spaghetti bolognaise and vegetables Puree lentil and vegetable soup Puree tinned fish (tuna, sardines, mackerel) with potato and vegetables Half your meal portion should be from a protein rich food
The FDAs compounding rules placed BPC-157 in a category of bulk substances that may present significant safety risks, which heavily restricts compounding pharmacies from making it
This phenomenon, sometimes called tolerance or dose creep, is reported anecdotally with tirzepatide, though the clinical trial data does not show significant tolerance development at fixed doses over 72 weeks
